Oncolix Inc. (fka ONCX)

[namtae]

Well, beginning with multiple statements of misinformation about how much debt Oncolix was carrying, to the following:

We know the notes have been renegotiated with interest accrued until April 2019. By then, we should have sufficient updates on Prolanta to justify a much higher PPS.

How does any non insider have knowledge of when we receive updates on Prolanta and whether those updates (if any) are positive or negative to justify a much higher share price

With positive news on their potential Cancer treatment, ONCX could see a PPS of $.50-$1.00 by then

.

Its a stretch to assume any potential updates on Prolanta will be positive. Its still phase 1 and 6 months have gone by without a peep (very disturbing and concerning).

Further, to suggest a .50 - $1.00 share price (up to $1billion market cap) on Phase 1 data is ridiculous!! Not to mention most of the shares outstanding & derivatives are at such a low cost basis, the market would need to eat through a massive amount of selling to even reach .20

That scenario seems to align with ONCX’s recent PR claiming to seek a NASDAQ listing in 2019

NASDAQ listing in 2019? lol Even with fairly good phase 1 results sometime in 2019, Oncolix would need to raise a ton of cash to qualify, among other items. It would also require the lender/investor to pay off existing debt or force a conversion. Good luck with that one too